Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders : workshop summary /
Sheena M. Posey Norris, Evelyn Strauss, Christopher DeFeo, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
- 1 online resource (1 PDF file (xiv, 114 pages)) : illustrations
Title from PDF title page.
Includes bibliographical references.
Introduction and overview -- Improving market protection -- Strengthening the regulatory pathway -- Patient benefit and engagement.
The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20-21, 2015, to explore policy changes that might increase private sector investment in research and development innovation that fills unmet medical needs for central nervous system (CNS) disorders. Workshop participants strategized about how to incentivize companies to fortify their CNS drug development programs, shrinking obstacles that currently deter ventures. Representatives from academia, government agencies, patient groups, and industry gathered to share information and viewpoints, and to brainstorm about budget-neutral policy changes that could help widen the pipeline toward drugs that address unmet needs for CNS disorders. This report summarizes the presentations and discussion of the workshop.
9780309373241 0309373247
101673538 DNLM
Drug development--Economic aspects--Congresses. Central nervous system--Diseases--Effect of drugs on--Congresses. Pharmaceutical industry--Economic aspects--Congresses. Public-private sector cooperation--Congresses. Central Nervous System Agents--economics. Drug Discovery--economics. Financial Support. Nervous System Diseases--drug therapy. Nervous System Diseases--economics. Private Sector--economics. MEDICAL--Pharmacology. Pharmaceutical industry--Economic aspects. Public-private sector cooperation.
Congress. Electronic books. Conference papers and proceedings.